- Home
- STBA vs BLDEW Comparison
STBA vs BLDEW Comparison
Compare STBA & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STBA
- BLDEW
- Stock Information
- Founded
- STBA 1902
- BLDEW 2014
- Country
- STBA United States
- BLDEW United States
- Employees
- STBA N/A
- BLDEW 281
- Industry
- STBA Major Banks
- BLDEW Transportation Services
- Sector
- STBA Finance
- BLDEW Consumer Discretionary
- Exchange
- STBA Nasdaq
- BLDEW Nasdaq
- Market Cap
- STBA N/A
- BLDEW N/A
- IPO Year
- STBA N/A
- BLDEW N/A
- Fundamental
- Price
- STBA $36.31
- BLDEW $0.19
- Analyst Decision
- STBA Hold
- BLDEW
- Analyst Count
- STBA 2
- BLDEW 0
- Target Price
- STBA $42.00
- BLDEW N/A
- AVG Volume (30 Days)
- STBA 132.8K
- BLDEW 51.0K
- Earning Date
- STBA 07-17-2025
- BLDEW 03-13-2025
- Dividend Yield
- STBA 3.75%
- BLDEW N/A
- EPS Growth
- STBA N/A
- BLDEW N/A
- EPS
- STBA 3.47
- BLDEW N/A
- Revenue
- STBA $386,868,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- STBA $5.86
- BLDEW N/A
- Revenue Next Year
- STBA $5.58
- BLDEW N/A
- P/E Ratio
- STBA $10.46
- BLDEW N/A
- Revenue Growth
- STBA 1.74
- BLDEW 12.04
- 52 Week Low
- STBA $29.85
- BLDEW $0.30
- 52 Week High
- STBA $45.79
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- STBA 43.63
- BLDEW N/A
- Support Level
- STBA $36.41
- BLDEW N/A
- Resistance Level
- STBA $37.47
- BLDEW N/A
- Average True Range (ATR)
- STBA 0.99
- BLDEW 0.00
- MACD
- STBA -0.22
- BLDEW 0.00
- Stochastic Oscillator
- STBA 14.85
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.